Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 7319143 Genetically-engineered MHC molecules
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
May 31, 2001
Date of Patent
January 15, 2008
Patent Application Number
10297060
Patent Citations Received
US Patent 12128069 Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
0
US Patent 11981731 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
0
US Patent 11999802 Compositions and methods for selective protein degradation
0
US Patent 11999794 Human mesothelin chimeric antigen receptors and uses thereof
0
US Patent 11667691 Treatment of cancer using chimeric CD3 receptor proteins
0
US Patent 11747346 Biomarkers predictive of cytokine release syndrome
US Patent 11851659 Compositions and methods for immunooncology
0
US Patent 11865167 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
0
US Patent 11872249 Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain
0
US Patent RE49847 Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
7319143
Patent Primary Examiner
Christina Chan
Find more entities like US Patent 7319143 Genetically-engineered MHC molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE